テキサスにおける非筋層浸潤性膀胱癌の臨床試験
テキサス内の拠点で、非筋層浸潤性膀胱癌に関する15件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Texas Oncology-Austin Central ( Site 0107), Austin
- Urology Austin, PLLC ( Site 0109), Austin
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06833073Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Urology Austin, Austin
- Urology Clinics of North Texas, Dallas
- Baylor College of Medicine, Houston
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Texas Oncology-Austin, Austin
- Urology Austin, Austin
- Urology San Antonio PA dba USA Clinical Trials, San Antonio
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06919965A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Cancer Center Outpatient Building, Dallas
- The University of Texas Southwestern Medical Center, Dallas
- UT Southwestern Medical Center - West Campus Building, Dallas
- 他5件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07206225A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
- UPNT Research Institute, Arlington
- UT Southwestern Medical Center, Dallas
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT07309445Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- UT Southwestern Medical Center, Dallas
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT05796375Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
- University of Texas Southwestern Medical Center, Dallas
- University of Texas Health Science Center at San Antonio, San Antonio
被験者募集中観察研究
18歳〜99歳 · 全性別 · 2026/08/24更新 · NCT05825950Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Urology Partners of North Texas, Arlington
- Urology Austin, LLC, Austin
- Houston Metro Urology, Houston
- 他2件
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/24更新 · NCT05951179Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
- Urology Partners of North Texas, Arlington
- Houston Metro Urology, Houston
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/21更新 · NCT07480356FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- University of Texas Southwestern, Dallas
- Texas Oncology, P.A, Dallas
- MD Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05614739Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)
- Natera, Inc., Austin
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/13更新 · NCT07763197LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Urology Austin, Austin
- UT Southwestern Medical Center, Dallas
- Houston Metro Urology, Houston
- 他2件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/07更新 · NCT04752722Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
- UT Southwestern Medical Center, Dallas
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/29更新 · NCT07673016A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
- University of Texas Southwestern Medical Center, Dallas
- Urology Partners of North Texas, Fort Worth
- Baylor College of Medicine, Houston
- 他2件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/27更新 · NCT05710848Blue Light Cystoscopy With Cysview® Registry
- UT Southwestern, Dallas
- Michael E. DeBakey VA Medical Center, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2025/12/18更新 · NCT02660645ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。